| Not Yet Recruiting | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) NCT06811454 | Case Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response NCT07129187 | Chuan Wang | Phase 2 |
| Recruiting | A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. NCT07095114 | Barbara Ann Karmanos Cancer Institute | N/A |
| Recruiting | A Study of Revaree Plus in People With Breast Cancer NCT07042581 | Memorial Sloan Kettering Cancer Center | Phase 4 |
| Recruiting | Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment NCT06087120 | Gene Solutions | — |
| Recruiting | TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Pat NCT05535192 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Improving Exercise Capacity With a Tailored Physical Activity Intervention NCT05595577 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer NCT05436808 | Stony Brook University | EARLY_Phase 1 |
| Recruiting | Comparison Between Prepectoral and Subpectoral Breast Reconstruction NCT05833659 | Beijing Friendship Hospital | — |
| Completed | Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748 | Barbara Ann Karmanos Cancer Institute | N/A |
| Active Not Recruiting | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer NCT04584255 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hor NCT04553770 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Researching the Effect of Exercise on Cancer NCT04589468 | Memorial Sloan Kettering Cancer Center | N/A |
| Active Not Recruiting | MARGetuximab Or Trastuzumab (MARGOT) NCT04425018 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protoc NCT04109391 | Tanvex BioPharma USA, Inc. | Phase 3 |
| Withdrawn | Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Can NCT03091842 | University of Southern California | N/A |
| Active Not Recruiting | Acupuncture Pilot Study for Cancer-related Cognitive Function NCT04007770 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Living Well After Breast Surgery NCT03834532 | University of Texas at Austin | N/A |
| Unknown | Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer NCT03691311 | Institut Català d'Oncologia | EARLY_Phase 1 |
| Completed | Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer NCT03556358 | Tanvex BioPharma USA, Inc. | Phase 3 |
| Active Not Recruiting | HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer NCT03387553 | H. Lee Moffitt Cancer Center and Research Institute | EARLY_Phase 1 |
| Active Not Recruiting | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa B NCT03414970 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer NCT03345420 | University of Utah | Phase 2 |
| Completed | Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy NCT03102866 | Ohio State University Comprehensive Cancer Center | N/A |
| Terminated | Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors NCT03284346 | University of Southern California | N/A |
| Terminated | Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage NCT03128619 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery NCT03113825 | Avelas Biosciences, Inc. | Phase 2 |
| Completed | Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer NCT03139435 | Wake Forest University Health Sciences | N/A |
| Completed | Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery NCT03188393 | NRG Oncology | Phase 2 |
| Active Not Recruiting | Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca NCT02957968 | Virginia Commonwealth University | Phase 2 |
| Completed | Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative NCT02780401 | University of Washington | Phase 1 |
| Active Not Recruiting | Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy NCT02445391 | ECOG-ACRIN Cancer Research Group | Phase 3 |
| Completed | Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering NCT03061175 | Rutgers, The State University of New Jersey | N/A |
| Completed | Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors NCT03198286 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Completed | Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III NCT02203552 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patient NCT02419807 | Case Comprehensive Cancer Center | N/A |
| Active Not Recruiting | T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA NCT02326974 | Dana-Farber Cancer Institute | Phase 2 |
| Active Not Recruiting | Energy Balance and Breast Cancer Aspects-II NCT02240836 | Oslo University Hospital | N/A |
| Completed | A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients NCT02129686 | Dana-Farber Cancer Institute | N/A |
| Unknown | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer NCT02115152 | Guangxi Medical University | Phase 2 |
| Completed | MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer NCT01805076 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin NCT02096588 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Terminated | Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Rad NCT02023008 | Wake Forest University Health Sciences | N/A |
| Active Not Recruiting | Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing NCT01953588 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Active Not Recruiting | Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Ca NCT01901094 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Ch NCT02002533 | Gary Morrow | N/A |
| Completed | Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cance NCT01941784 | Wake Forest University Health Sciences | N/A |
| Terminated | PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer NCT01712815 | University of Southern California | N/A |
| Completed | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer NCT01869764 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III NCT01959490 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Pro NCT03233555 | Rutgers, The State University of New Jersey | N/A |
| Active Not Recruiting | Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Tre NCT01872975 | NSABP Foundation Inc | N/A |
| Active Not Recruiting | A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) NCT01824836 | ECOG-ACRIN Cancer Research Group | N/A |
| Unknown | Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer NCT01800422 | Northwestern University | Phase 2 |
| Terminated | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery NCT01754519 | Roswell Park Cancer Institute | Phase 2 |
| Completed | Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Br NCT01818063 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Active Not Recruiting | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Brea NCT01750073 | University of Nebraska | Phase 2 |
| Terminated | Light-Scattering Spectroscopy for Detection of Breast Cancer NCT01755208 | University of Southern California | N/A |
| Withdrawn | Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer NCT01695057 | University of Southern California | N/A |
| Completed | Phase I: At-Home Support for Rural Women Using Group Video Calling NCT01672684 | Stanford University | Phase 1 |
| Terminated | Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors NCT01628887 | City of Hope Medical Center | N/A |
| Completed | Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer NCT01632332 | Mayo Clinic | Phase 1 |
| Completed | Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer NCT01688609 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Exercise Program for Early Breast Cancer Survivors NCT01140282 | University of Southern California | N/A |
| Completed | Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery NCT01483196 | Wake Forest University Health Sciences | N/A |
| Terminated | FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer NCT01931709 | University of Washington | N/A |
| Completed | Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastroz NCT01478477 | Ohio State University Comprehensive Cancer Center | N/A |
| Terminated | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive NCT01368263 | Washington University School of Medicine | Phase 2 |
| Unknown | Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients NCT01372579 | Northwestern University | Phase 2 |
| Terminated | Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer NCT01394211 | University of Arizona | Phase 2 |
| Completed | Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER NCT01355393 | University of Washington | Phase 1 / Phase 2 |
| Completed | Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Bre NCT01293032 | Virginia Commonwealth University | N/A |
| Terminated | A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer NCT01194427 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer NCT01431196 | Clinica Universidad de Navarra, Universidad de Navarra | Phase 2 |
| Completed | Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms NCT01194440 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Completed | Diindolylmethane in Treating Patients With Breast Cancer NCT01391689 | University of Arizona | N/A |
| Withdrawn | Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer NCT01729832 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing NCT01982591 | Fox Chase Cancer Center | — |
| Withdrawn | Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By NCT01292083 | University of Southern California | N/A |
| Completed | Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer NCT01417286 | Rutgers, The State University of New Jersey | Phase 2 |
| Terminated | Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and NCT01276054 | University of Southern California | Phase 2 |
| Terminated | Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Recei NCT01243541 | Northwestern University | N/A |
| Terminated | RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III NCT01208441 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery NCT01234532 | University of Maryland, Baltimore | Phase 2 |
| Terminated | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT01233505 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Endoscopic Breast Surgery in Treating Patients With Breast Cancer NCT01222377 | University of Southern California | N/A |
| Completed | Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer NCT01219075 | University of Southern California | N/A |
| Completed | Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors NCT01113554 | Wake Forest University Health Sciences | N/A |
| Completed | Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy NCT01487954 | Case Comprehensive Cancer Center | Phase 2 |
| Withdrawn | Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer NCT01100489 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Ca NCT01051401 | Wake Forest University Health Sciences | Phase 1 |
| Terminated | Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Rece NCT01050075 | City of Hope Medical Center | N/A |
| Completed | Window of Opportunity Study Targeting the Inflammatory Milieu NCT01881048 | University of Colorado, Denver | EARLY_Phase 1 |
| Completed | MUC1 Vaccine for Triple-negative Breast Cancer NCT00986609 | Joseph Baar, MD, PhD | EARLY_Phase 1 |
| Completed | Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Rela NCT01013337 | Abramson Cancer Center at Penn Medicine | N/A |
| Completed | Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients NCT01723943 | University of Washington | N/A |
| Terminated | Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breas NCT00679029 | University of Nebraska | Phase 2 |
| Completed | Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting NCT00618657 | University of California, Irvine | Phase 2 |
| Completed | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Ca NCT00513292 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer NCT00516243 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patie NCT00513695 | University of Washington | Phase 2 |
| Completed | Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer NCT00470301 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole NCT00416715 | University of Washington | Phase 2 |
| Completed | Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breas NCT01043003 | City of Hope Medical Center | N/A |
| Completed | Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanopart NCT00407888 | University of Washington | Phase 2 |
| Completed | Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in NCT00343863 | University of Washington | N/A |
| Completed | Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI NCT02587663 | University of Southern California | N/A |
| Completed | Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer NCT00119262 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer NCT00262834 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA B NCT00194792 | University of Washington | Phase 2 |
| Terminated | Capecitabine in Women With Operable Breast Cancer NCT00148720 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer T NCT00194779 | University of Washington | Phase 2 |
| Completed | Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer NCT00146562 | Harold J. Burstein, MD, PhD | Phase 2 |
| Completed | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer NCT00070057 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer NCT00049114 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer NCT00146588 | Craig A. Bunnell, MD, MPH | N/A |
| Completed | Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors NCT01831076 | University of Colorado, Denver | Phase 2 |
| Completed | Preoperative Herceptin and Navelbine for Breast Cancer NCT00148681 | Dana-Farber Cancer Institute | Phase 2 |
| Terminated | Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer NCT00019643 | National Institutes of Health Clinical Center (CC) | — |
| Withdrawn | Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Po NCT00080613 | Robert H. Lurie Cancer Center | Phase 2 |